Seek emergency medical care if you experience systemic symptoms or if the rash worsens
Injection site reactions on tirzepatide Injection site reactions redness, swelling, itching, or a small bruise at the site occurred in 3.2% of Mounjaro users versus 0.4% of placebo participants in the SURPASS trials, per the prescribing information
Exploring the weight loss benefits, side effects, and cost What does not losing weight on Zepbound actually mean
are supported by binational FNR/DFG program: the FNR-CORE grant (C18/BM/12691266) and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) project HI1400/3-1
Third, the optimal positioning and sequencing of GLP-1-based therapies relative to resmetirom and other emerging MASH agents (e.g., lanifibranor, pegozafermin, semaglutide combination regimens) requires dedicated combination trials, of which preliminary data from the MAESTRO-NASH secondary analysis are encouraging